| The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria P Hillmen, NS Young, J Schubert, RA Brodsky, G Socié, P Muus, A Röth, ... New England Journal of Medicine 355 (12), 1233-1243, 2006 | 1322 | 2006 |
| Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation R Childs, A Chernoff, N Contentin, E Bahceci, D Schrump, S Leitman, ... New England Journal of Medicine 343 (11), 750-758, 2000 | 1308 | 2000 |
| Parvovirus B19 NS Young, KE Brown New England Journal of Medicine 350 (6), 586-597, 2004 | 1122 | 2004 |
| Current concepts in the pathophysiology and treatment of aplastic anemia NS Young, RT Calado, P Scheinberg Blood 108 (8), 2509-2519, 2006 | 1121 | 2006 |
| Erythrocyte P antigen: cellular receptor for B19 parvovirus KE Brown, SM Anderson, NS Young Science 262 (5130), 114-117, 1993 | 1077 | 1993 |
| Diagnosis and management of paroxysmal nocturnal hemoglobinuria C Parker, M Omine, S Richards, J Nishimura, M Bessler, R Ware, ... Blood 106 (12), 3699-3709, 2005 | 1036 | 2005 |
| Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major GM Brittenham, PM Griffith, AW Nienhuis, CE McLaren, NS Young, ... New England Journal of Medicine 331 (9), 567-573, 1994 | 1029 | 1994 |
| Telomere diseases RT Calado, NS Young New England Journal of Medicine 361 (24), 2353-2365, 2009 | 941 | 2009 |
| Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia H Yamaguchi, RT Calado, H Ly, S Kajigaya, GM Baerlocher, SJ Chanock, ... New England Journal of Medicine 352 (14), 1413-1424, 2005 | 824 | 2005 |
| The pathophysiology of acquired aplastic anemia NS Young, J Maciejewski New England journal of medicine 336 (19), 1365-1372, 1997 | 706 | 1997 |
| Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses R Childs, E Clave, N Contentin, D Jayasekera, N Hensel, S Leitman, ... Blood, The Journal of the American Society of Hematology 94 (9), 3234-3241, 1999 | 667 | 1999 |
| Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria RA Brodsky, NS Young, E Antonioli, AM Risitano, H Schrezenmeier, ... Blood, The Journal of the American Society of Hematology 111 (4), 1840-1847, 2008 | 664 | 2008 |
| Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria P Hillmen, P Muus, U Dührsen, AM Risitano, J Schubert, L Luzzatto, ... Blood, The Journal of the American Society of Hematology 110 (12), 4123-4128, 2007 | 658 | 2007 |
| 5-Azacytidine selectively increases γ-globin synthesis in a patient with β+ thalassemia TJ Ley, J DeSimone, NP Anagnou, GH Keller, RK Humphries, PH Turner, ... New England Journal of Medicine 307 (24), 1469-1475, 1982 | 644 | 1982 |
| Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in … J Maciejewski, C Selleri, S Anderson, NS Young | 616 | 1995 |
| Why current publication practices may distort science NS Young, JPA Ioannidis, O Al-Ubaydli PLoS medicine 5 (10), e201, 2008 | 603 | 2008 |
| Somatic mutations and clonal hematopoiesis in aplastic anemia T Yoshizato, B Dumitriu, K Hosokawa, H Makishima, K Yoshida, ... New England Journal of Medicine 373 (1), 35-47, 2015 | 563 | 2015 |
| Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation CE Dunbar, M Cottler-Fox, JA O'Shaughnessy, S Doren, C Carter, ... | 561 | 1995 |
| Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS N Frickhofen, JL Abkowitz, M Safford, JM Berry, J Antunez-de-Mayolo, ... Annals of internal medicine 113 (12), 926-933, 1990 | 546 | 1990 |
| Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy G Kurtzman, N Frickhofen, J Kimball, DW Jenkins, AW Nienhuis, ... New England Journal of Medicine 321 (8), 519-523, 1989 | 546 | 1989 |
John BarrettChief Stem Cell Transplant Section, Hematology Branch在 nih.gov 的电子邮件经过验证
